Post-Immunotherapy Combo Promising in Advanced RCC

[MEDPAGE TODAY]( Oncology Update Tuesday, April 04, 2023 [Post-Immunotherapy Combo Promising in Advanced RCC]( [FDA Greenlights New First-Line Regimen in Bladder Cancer]( [Does Your 80-Year-Old Patient Really Need That Colonoscopy?]( ADVERTISEMENT Exclusives & Features [How Much Do Doctors Bill Commercial Insurers?]( [Nearly All Hospital Websites Send Tracking Data to Third Parties]( [OTC Narcan Approval Opens New Doors in Fight Against Opioid Crisis]( [Breaking Bad: the antihero's journey through cancer]( Breaking Bad is a cable TV series that transformed a modest high school chemistry teacher, Walter White, into a ruthless drug kingpin after he was diagnosed with lung cancer, bringing attention to... [READ MORE]( [Trends in health care spending on kidney cancer in the United States, 1996-2016.]( BACKGROUND: Paradigm shifts in kidney cancer management have led to higher health care spending. Here, total and per capita health care spending and primary drivers of change in health expenditures... [READ MORE]( [Efficacy and safety of nilotinib in chronic myeloid leukaemia patients who failed to achieve a treatment-free remission period after imatinib discontinuation: Results of the French Nilo post-STIM study.]( Molecular recurrence (MRec) occurs in about half of all patients with chronic myeloid leukaemia (CML) who discontinue tyrosine kinase inhibitors (TKI) in sustained deep molecular response. A second... [READ MORE]( [Modeling hemoglobin levels of patients chronically transfused with red blood cells.]( BACKGROUND: Good models of chronic red blood cell (RBC) transfusion can improve care by accurately estimating time-dependent hemoglobin (Hb) levels and clinically relevant transfusion... [READ MORE]( [Atrium Health Wake Forest Baptist using AI, robotics to diagnose lung cancer]( Winston-Salem, N.C.-based Atrium Health Wake Forest Baptist is using artificial intelligence and robotics to help clinicians predict and diagnose lung cancer. [READ MORE]( [A Property of Everyday Health group]( © 2023 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Spec_Oncology_Update?xid=nl_mpt_Oncology_update_2023-04-04&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 5th Avenue, 15th Floor New York, NY 10011